1. Pretreatment thrombocytosis as an independent predictive factor for chemoresistance and poor survival in epithelial ovarian cancer Nakao, Sari, Minaguchi, Takeo, Itagaki, Hiroya, Hosokawa, Yoshihiko, Shikama, Ayumi, Tasaka, Nobutaka, Akiyama, Azusa, Ochi, Hiroyuki, Matsumoto, Koji, Satoh, Toyomi JOURNAL OF OVARIAN RESEARCH 13 (1) (2020)
2. Ovarian metastases from ileum cancer in a patient with germline EPCAM gene deletion successfully treated with surgical resection and CAPOX chemotherapy: a case report Iwata, Narushi, Shikama, Ayumi, Takao, Wataru, Hosokawa, Yoshihiko, Itagaki, Hiroya, Tasaka, Nobutaka, Akiyama, Azusa, Ochi, Hiroyuki, Minaguchi, Takeo, Arita, Miwa, Noguchi, Emiko, Moriwaki, Toshikazu, Satoh, Toyomi BMC medical genetics 21 (1) 76 (2020)
3. Prevalence of venous thromboembolism at pretreatment screening and associated risk factors in 2086 patients with gynecological cancer. N, Tasaka, T, Minaguchi, Y, Hosokawa, W, Takao, H, Itagaki, K, Nishida, A, Akiyama, A, Shikama, H, Ochi, Satoh, Toyomi J Obstet Gynaecol Res. 46 (5) 765 - 773 (2020)
4. PD-L1 and CD4 are independent prognostic factors for overall survival in endometrial carcinomas Zhang, Shuang, Minaguchi, Takeo, Xu, Chenyang, Qi, Nan, Itagaki, Hiroya, Shikama, Ayumi, Tasaka, Nobutaka, Akiyama, Azusa, Sakurai, Manabu, Ochi, Hiroyuki, Satoh, Toyomi BMC cancer 20 (1) 127 (2020)
5. Abnormal accumulation of p53 predicts radioresistance leading to poor survival in patients with endometrial carcinoma Akiyama, Azusa, Minaguchi, Takeo, Fujieda, Kaoru, Hosokawa, Yoshihiko, Nishida, Keiko, Shikama, Ayumi, Tasaka, Nobutaka, Sakurai, Manabu, Ochi, Hiroyuki, Satoh, Toyomi Oncology letters 18 (6) 5952 - 5958 (2019)
6. Predictors of favorable survival after secondary cytoreductive surgery for recurrent endometrial cancer Shikama, Ayumi, Minaguchi, Takeo, Takao, Wataru, Hosokawa, Yoshihiko, Nishida, Keiko, Tasaka, Nobutaka, Akiyama, Azusa, Sakurai, Manabu, Ochi, Hiroyuki, Satoh, Toyomi International journal of clinical oncology 24 (10) 1256 - 1263 (2019)
7. Human papillomavirus genotype and prognosis of cervical cancer: Favorable survival of patients with HPV16-positive tumors Onuki, Mamiko, Matsumoto, Koji, Tenjimbayashi, Yuri, Tasaka, Nobutaka, Akiyama, Azusa, Sakurai, Manabu, Minaguchi, Takeo, Oki, Akinori, Satoh, Toyomi, Yoshikawa, Hiroyuki Papillomavirus research (Amsterdam, Netherlands) 6 41 - 45 (2018)
8. PD-L1 EXPRESSION IS AN INDEPENDENT PROGNOSTIC FACTOR FOR SURVIVAL IN ENDOMETRIAL CARCINOMAS Zhang, S, Minaguchi, T, Shikama, A, Qi, N, Xu, C, Liu, S, Lachkar, B, Tasaka, N, Akiyama, A, Sakurai, M, Ochi, H, Satoh, T INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 28 (2) 81 - 81 (2018)
9. PROGNOSTIC IMPACT OF PIK3CA MUTATIONAL STATUS IN STAGE IIB TO IVA CERVICAL CANCERS TREATED BY CONCURRENT CHEMORADIOTHERAPY WITH WEEKLY CISPLATIN Lachkar, B, Minaguchi, T, Akiyama, A, Liu, S, Zhang, S, Xu, C, Qi, N, Shikama, A, Tasaka, N, Sakurai, M, Ochi, H, Yoshikawa, H, Satoh, T INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 28 (2) 320 - 320 (2018)
10. SEPARATE ANALYSIS OF HUMAN PAPILLOMAVIRUS E6 AND E7 MRNAS IN CERVICAL NEOPLASTIC DISEASES Liu, S, Minaguchi, T, Lachkar, B, Zhang, S, Xu, C, Qi, N, Tenjimbayashi, Y, Shikama, A, Tasaka, N, Akiyama, A, Sakurai, M, Ochi, H, Onuki, M, Matsumoto, K, Yoshikawa, H, Satoh, T INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 28 (2) 328 - 328 (2018)

論文リストをさらに表示する Show more